Economic impact of cost-containment strategies in third party programmes in the US (part I).
Pharmacoeconomics. 1993 Aug;4(2):92-103. doi: 10.2165/00019053-199304020-00004.
Pharmacoeconomics. 1993.
PMID: 10146971